Pediatric sublingual allergen immunotherapy

被引:5
|
作者
Blaiss, Michael S. [1 ]
机构
[1] Augusta Univ, Med Coll Georgia, Dept Pediat, Augusta, GA USA
关键词
MITE-SENSITIZED CHILDREN; DOUBLE-BLIND; ATOPIC-DERMATITIS; EAACI GUIDELINES; EFFICACY; SAFETY; RHINITIS; RHINOCONJUNCTIVITIS; ASTHMA;
D O I
10.2500/aap.2022.43.210079
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Sublingual immunotherapy (SLIT) offers an important therapeutic modality in the management of children with respiratory allergies. Along with subcutaneous immunotherapy, these modalities are the only selections that have shown not merely relief of symptoms but also disease-modifying activity. SLIT can be given as either a dissolvable tablet (SLIT-T) or liquid drops (SLIT-D). In studies that examined the efficacy and safety in allergic rhinitis and asthma, SLIT-T and SLIT-D both show efficacy in reducing symptoms and the need for medication, although it seems that SLIT-T may show a better response. Almost all SLIT-D efficacy studies are with single allergens. There are virtually no data on the efficacy of mixing unrelated allergens in the same prescription. Both SLIT-T and SLIT-D treatments are safe, with the most common adverse effects being local ones, such as oral pruritus and mouth irritation, which tend to be mild and short lived. Studies that assess the role of SLIT in the prevention of new sensitizations and asthma in the pediatric population are insufficient and of mixed results; therefore, no conclusions can be made. In the treatment of other pediatric conditions, such as food allergy and atopic dermatitis, there are few studies that assessed if, and the degree of, the benefit with SLIT. In determining if SLIT should be prescribed for the pediatric patient, there is a need for shared decision-making to allow the older child and parents or caregivers to understand the pros and cons, and the costs of all the options and relate their values and preferences to the physician.
引用
收藏
页码:281 / 285
页数:5
相关论文
共 50 条
  • [21] Dropouts in sublingual allergen immunotherapy trials - a systematic review
    Makatsori, M.
    Scadding, G. W.
    Lombardo, C.
    Bisoffi, G.
    Ridolo, E.
    Durham, S. R.
    Senna, G.
    ALLERGY, 2014, 69 (05) : 571 - 580
  • [22] Immune mechanisms of allergen-specific sublingual immunotherapy
    Van Overtvelt, L.
    Batard, T.
    Fadel, R.
    Moingeon, P.
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 2006, 46 (08): : 713 - 720
  • [23] Adjuvants and formulations for allergen-specific sublingual immunotherapy
    Van Overtvelt, L.
    Lombardi, V.
    Saint-Lu, N.
    Mascarell, L.
    Tourdot, S.
    Moingeon, P.
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 2008, 48 (03): : 127 - 129
  • [24] Sublingual allergen immunotherapy in Tunisia: Safety and efficacy profile
    Daboussi, S.
    Mhamdi, S.
    Aichaouia, C.
    Moetamri, Z.
    Mejri, I
    Khadraoui, M.
    Cheikh, R.
    REVUE FRANCAISE D ALLERGOLOGIE, 2018, 58 (04): : 299 - 303
  • [25] Development of an allergen extract for sublingual immunotherapy - evaluation of Staloral
    Frati, Franco
    Scurati, Silvia
    Puccinelli, Paola
    Luis Justicia, Jose
    Adamec, Thomas
    Sieber, Hans Jochen
    Ras, Lisbeth
    David, Marie
    Marcucci, Francesco
    Incorvaia, Cristoforo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (09) : 1207 - 1215
  • [26] Eosinophilic esophagitis during sublingual and oral allergen immunotherapy
    Cafone, Joseph
    Capucilli, Peter
    Hill, David A.
    Spergel, Jonathan M.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 19 (04) : 350 - 357
  • [27] Allergen-Specific Sublingual Immunotherapy for Respiratory Allergy
    Giovanni Passalacqua
    Giorgio Walter Canonica
    BioDrugs, 2001, 15 : 509 - 519
  • [28] Role of IL-35 in sublingual allergen immunotherapy
    Shamji, Mohamed H.
    Layhadi, Janice A.
    Achkova, Daniela
    Kouser, Lubna
    Perera-Webb, Alan
    Couto-Francisco, Natalia C.
    Parkin, Rebecca V.
    Matsuoka, Tomokazu
    Scadding, Guy
    Ashton-Rickardt, Philip G.
    Durham, Stephen R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (03) : 1131 - +
  • [29] Prolonged effect of allergen sublingual immunotherapy to grass pollen
    Bozek, Andrzej
    Jakalski, Marek
    Jonska-Golus, Monika
    Filipowska-Gronska, Agata
    Jarzab, Jerzy
    Canonica, Giorgio Walter
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (12) : 2842 - 2847
  • [30] Sublingual allergen immunotherapy in HIV-positive patients
    Iemoli, E.
    Borgonovo, L.
    Fusi, A.
    Magni, C.
    Ricci, E. D.
    Rizzardini, G.
    Piconi, S.
    ALLERGY, 2016, 71 (03) : 412 - 415